BRAMPTON — Grocery and drugstore retailer Loblaw Cos. Ltd. reported its third-quarter profit and revenue rose compared with a year ago.
The company behind Loblaws and Shoppers Drug Mart says it earned a profit attributable to common shareholders of $794 million or 66 cents per diluted share for the quarter ended Oct. 4.
The result compared with a profit of $777 million or 63 cents per diluted share in the same quarter last year.
Revenue for the 16-week period totalled $19.40 billion, up from $18.54 billion a year earlier.
The company’s hard discount and Real Canadian Superstore banners outperformed its conventional stores as consumers continue to hunt for value, Loblaw said in a release.
Food retail same-store sales were up two per cent, while drug retail same-store sales rose four per cent with pharmacy and health-care same-store sales growth of 5.9 per cent and a gain of 1.9 per cent for front store same-store sales.
RBC analyst Irene Nattel said in a note to clients it was “another solid quarter” for the company, however, same-store food sales and revenue was “a string bean shy of forecast.”
On an adjusted basis, Loblaw says its earned 69 cents per diluted share in its latest quarter, up from an adjusted profit of 62 cents per diluted share a year ago.
This report by The Canadian Press was first published Nov. 12, 2025.
Companies in this story: (TSX: L)
The Canadian Press